Related Experiment Videos
Increased protein nitrosylation in head and neck squamous cell carcinogenesis
B G Bentz1, G K Haines, J A Radosevich
1Department of Otolaryngology-Head & Neck Surgery and the Robert H. Lurie Cancer Center, Northwestern University Medical School, Searle 12-561, 303 East Chicago Ave., Chicago, IL 60611-3008, USA.
Head & Neck
|December 10, 1999
Summary
Nitrotyrosine, a marker of nitric oxide (NO) byproducts, increases in head and neck squamous cell carcinoma (HNSCCa). This suggests NO may play a role in HNSCCa development and immune suppression.
Area of Science:
- Oncology
- Biochemistry
- Immunology
Background:
- Nitric oxide (NO) and its metabolites are linked to cancer development.
- Nitrotyrosine, a marker of protein nitrosylation by NO-species, is investigated in head and neck squamous cell carcinoma (HNSCCa).
Purpose of the Study:
- To examine nitrotyrosine staining intensity as a marker of NO-species' activity during HNSCCa development.
- To correlate nitrotyrosine levels with clinical data in HNSCCa progression.
Main Methods:
- Immunohistochemical analysis of paraffin-embedded tissue samples from normal oral mucosa, hyperplasia/dysplasia, and HNSCCa.
- Quantification of nitrotyrosine staining intensity using a specific monoclonal antibody.
- Retrospective correlation with clinical data.
Main Results:
- Significantly elevated nitrotyrosine staining was observed in reactive, dysplastic, and HNSCCa tissues compared to normal oral mucosa.
- Distinct differences in staining intensity were noted across various upper aerodigestive tract primary sites.
- Intense nitrotyrosine staining was also detected in individual inflammatory cells.
Conclusions:
- Nitrotyrosine staining increases progressively from normal mucosa through reactive/dysplastic lesions to HNSCCa.
- Inflammatory cell staining suggests a potential role for NO in mediating immunosuppression within the tumor microenvironment.
- Further research is warranted to elucidate the role of NO in HNSCCa mutagenesis and immunosuppression.